Development of a three-dimensional bioengineering technology to generate lung tissue for personalized disease modeling

Stem Cells Translational Medicine

Volumn 6, Issue 2, 2017, Pages 622-633

  Wilkinson, Dan C ^a   Alva Ornelas, Jackelyn A ^b   Sucre, Jennifer M S ^b   Vijayaraj, Preethi ^b   Durra, Abdo ^b   Richardson, Wade ^a   Jonas, Steven J ^b   Paul, Manash K ^b   Karumbayaram, Saravanan ^c   Dunn, Bruce ^a   Gomperts, Brigitte N ^b,c  

^a Engineering IV   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease modeling; Lung; Three dimensional cell culture; Tissue engineering

Indexed keywords

COLLAGEN TYPE 1; HYDROXYPROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOENGINEERING; CELL ADHESION; CELL CONTACT; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INDUCED PLURIPOTENT STEM CELL; LUNG PARENCHYMA; MICROENVIRONMENT; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; BIOREACTOR; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL LINEAGE; DEVICES; DRUG EFFECT; FIBROBLAST; LUNG; ORGANOID; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; TIME FACTOR; TISSUE ENGINEERING;

BIOREACTORS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; FIBROBLASTS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INDUCED PLURIPOTENT STEM CELLS; LUNG; ORGANOIDS; PHENOTYPE; TIME FACTORS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85017617797     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2016-0192     Document Type: Article

References (37)

1. NIH NHLBI. Chapter 4 Disease Statistics. NHLBI FACT BOOK, FISC. YEAR 2012 2012:33–52. Available at: https://http://www.nhlbi.nih.gov/about/factbook/chapter4.htm#gr36\nhttp://www.nhlbi.nih.gov/about/documents/factbook/2012. Accessed November 10, 2015.
2. Hubbard R. The burden of lung disease. Thorax 2006;61:557–558.
3. Rackley CR, Stripp BR. Building and maintaining the epithelium of the lung. J Clin Invest 2012;122:2724–2730.
4. Moeller A, Ask K, Warburton D et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008;40: 362–382.
5. Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134: 136–151.
6. Weiss DJ. Concise review: Current status of stem cells and regenerative medicine in lung biology and diseases. STEM CELLS 2014;32:16–25.
7. Sucre JMS, Wilkinson D, Vijayaraj P et al. A three-dimensional human model of the fibroblast activation that accompanies bronchopulmonary dysplasia identifies Notch-mediated pathophysiology. Am J Physiol Lung Cell Mol Physiol 2016;310:L889–L898.
8. Calle EA, Mendez JJ, Ghaedi M et al. Fate of distal lung epithelium cultured in a decellularized lung extracellular matrix. Tissue Eng Part A 2015;21:1916–1928.
9. Ren X, Moser PT, Gilpin SE et al. Engineering pulmonary vasculature in decellularized rat and human lungs. Nat Biotechnol 2015;33:1097–1102.
10. Andrade CF, Wong AP, Waddell TK et al. Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol 2007; 292:L510–L518.
11. Singh D, Zo SM, Kumar A et al. Engineering three-dimensional macroporous hydroxyethyl methacrylate-alginate-gelatin cryogel for growth and proliferation of lung epithelial cells. J Biomater Sci Polym Ed 2013;24:1343–1359.
12. Gill BJ, Gibbons DL, Roudsari LC et al. A synthetic matrix with independently tunable biochemistryandmechanicalproperties tostudy epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res 2012;72: 6013–6023.
13. Zhang W-J, Lin Q-X, Zhang Y et al. The reconstruction of lung alveolus-like structure in collagen-matrigel/microcapsules scaffolds in vitro. J Cell Mol Med 2011;15:1878–1886.
14. Franzdóttir SR, Axelsson IT, Arason AJ et al. Airway branching morphogenesis in three dimensional culture. Respir Res 2010; 11:162.
15. Kaisani A, Delgado O, Fasciani G et al. Branching morphogenesis of immortalized human bronchial epithelial cells in three-dimensional culture. Differentiation 2014;87:119–126.
16. Dye BR, Hill DR, Ferguson MAH et al. In vitro generation of human pluripotent stem cell derived lung organoids. eLife 2015;4:1–25.
17. Barkauskas CE, Cronce MJ, Rackley CR et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013;123:3025–3036.
18. Lee JH, Bhang DH, Beede A et al. Lung stemcell differentiation inmice directed by endothelial cells via aBMP4-NFATc1-thrombospondin-1 axis. Cell 2014;156:440–455.
19. Gotoh S, Ito I, Nagasaki T et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Rep 2014;3:394–403.
20. Teisanu RM, Chen H, Matsumoto K et al. Functional analysis of two distinct bronchiolar progenitors during lung injury and repair. Am J Respir Cell Mol Biol 2011;44:794–803.
21. Karumbayaram S, Lee P, Azghadi SF et al. From skin biopsy to neurons through a pluripotent intermediate under Good Manufacturing Practice protocols. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:36–43.
22. Shamis Y, Silva EA, Hewitt KJ et al. Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo. PLoS One 2013;8:e83755.
23. Samuel CS. Kidney research. In: Hewitson TD, Becker GJ, eds. Methods in Molecular Biology, Vol 466. Totowa, NJ:HumanaPress, 2009:223–235.
24. Bugarski B, Li Q, Goosen MFA et al. Electrostatic droplet generation: Mechanism of polymer droplet formation. AIChE J 1994;40: 1026–1031.
25. Hunt NC, Grover LM. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 2010;32:733–742.
26. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999;20:45–53.
27. Lee H, Dellatore SM, Miller WM et al. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007;318:426–430.
28. Yu X, Walsh J, Wei M. Covalent immobilization of collagen on titanium through polydopamine coating to improve cellular performances of MC3T3-E1 cells. RSC Advances 2013;4: 7185–7192.
29. Dunsmore SE, Rannels DE. Extracellular matrix biology in the lung. Am J Physiol 1996; 270:L3–L27.
30. Takebe T, Enomura M, Yoshizawa E et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell 2015;16:556–565.
31. Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol 2011;73:413–435.
32. Miki H, Mio T, Nagai S et al. Fibroblast contractility: Usual interstitial pneumonia and nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2000;162:2259–2264.
33. Carloni A, Poletti V, Fermo L et al. Heterogeneous distribution of mechanical stress in humanlung: Amathematical approach to evaluate abnormal remodeling in IPF. J Theor Biol 2013; 332:136–140.
34. Selman M, Pardo A, Kaminski N. Idiopathic pulmonary fibrosis: Aberrant recapitulation of developmental programs? PLoS Med 2008;5:e62.
35. Pierce EM, Carpenter K, Jakubzick C et al. Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 2007;29:1082–1093.
36. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nat Med 2012;18:1028–1040.
37. Nichols JE, Cortiella J. Engineering of a complex organ: Progress toward development of a tissue-engineered lung. Proc Am Thorac Soc 2008;5:723–730.